Personalized medicine has been at the forefront of research on CF, where the underlying cause is a genetic mutation in CFTR, and thus recent therapies have primarily focused on correction, potentiation, and read-through approaches to restore the functional CFTR protein. The gene discussed is CFTR; the disease is cystic fibrosis.